Safety and Health at Work

Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency (산업안전보건연구원)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of the Genetic Toxicity of Cyclopentane and Ammonium Nitrate - In vitro Mammalian Chromosomal Aberration Assay in Chinese Hamster Ovary Cells

  • Kim, Soo-Jin (Center for Chemical Safety and Health, Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency) ;
  • Rim, Kyung-Taek (Center for Chemical Safety and Health, Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency) ;
  • Kim, Jong-Kyu (Center for Chemical Safety and Health, Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency) ;
  • Kim, Hyeon-Yeong (Center for Chemical Safety and Health, Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency) ;
  • Yang, Jeong-Sun (Center for Chemical Safety and Health, Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency)
  • Received : 2010.06.18
  • Accepted : 2010.07.24
  • Published : 2011.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: In this study, the in vitro mammalian chromosomal aberration (CA) assay was conducted to gain additional information concerning the hazards associated with the use of cyclopentane and ammonium nitrate. While these two chemicals had already been tested by many methods, they had not been studied in the CA test. Methods: The assay was performed using the ovarian infantile cell (CHO-K1 cell), by the direct method (-S9) and by the metabolic activated method (+S9 mix). Results: Using the direct method, the 7 dosages in a 48 hour treatment group did not show that the frequency of CA is proportion to the dosage addition. The frequency of CA is not proportion to the dosage addition for a 6 hour treatment using the metabolic activated method. Conclusion: From these findings, it was decided that the 2 chemicals do not induce chromosomal aberrations under the tested conditions.

Keywords

References

  1. American Coference of Governmental Industrial Hygienists. TLV for chemical substances and physical agents and BEI for 1991-1992. Cincinnati (OH): 1991.
  2. Clayton GD. Toxicology. In: Clayton FE, editor. Patty's industrial hygiene and toxicology. Vol 2, Part B. 4th ed. New York: John Wiley & Sons; 1993. p. 1268-73.
  3. Brown VK, Box VL. The influence of some alicyclic hydrocarbons on the arginase activity of guinea-pig skin. Br J Dermatol 1971;85:432-6. https://doi.org/10.1111/j.1365-2133.1971.tb14049.x
  4. Litovitz T. Myocardial sensitization following inhalational abuse of hydrocarbons. Occup Med 1988;3:567-8.
  5. Gerarde HW. The alicyclic hydrocarbons industrial hygiene and toxicology. In: Pan Y, et al, editors. Clinical ecology. Vol 2. New York: Interscience Publishers; 1963, 1988. p. 126-31.
  6. Pan Y, Johnson AR, Rea WJ. Aliphatic hydrocarbon solvents in chemically sensitive patients. Clinical Ecology 1988;5:126-31.
  7. Pan Y, Johnson AR, Rea WJ. Aliphatic hydrocarbon solvents in chemically sensitive patients. Bol Asoc Med P R 1991;83:316-20.
  8. Simonsen L, Lund SP. A strategy for delineating risks due to exposure to neurotoxic chemicals. Am J Ind Med 1992;21:773-92. https://doi.org/10.1002/ajim.4700210602
  9. Verma DK, Julian JA, Bebee G, Cheng WK, Holborn K, Shaw L. Hydrocarbon exposures at petroleum bulk terminals and agencies. Am Ind Hyg Assoc J 1992;53:645-56. https://doi.org/10.1080/15298669291360292
  10. Ellen G, Schuller PL, Froeling PG, Bruijns E. No volatile Nnitrosamines detected in blood and urine from patients ingesting daily large amounts of ammonium nitrate. Food Chem Toxicol 1982;20:879-82. https://doi.org/10.1016/S0015-6264(82)80221-6
  11. National Toxicology Program. National Toxicology Program, within the U.S. Department of Health and Human Services, is an interagency program headquartered at the National Institutes of Health's National Institute of Environmental Health Sciences (NIEHS). Research Triangle Park (NC): 2000. Report No.: A90637.
  12. National Toxicology Program. National Toxicology Program, within the U.S. Department of Health and Human Services, is an interagency program headquartered at the National Institutes of Health's National Institute of Environmental Health Sciences. Research Triangle Park (NC): 1990. Report No.: A53723.
  13. World Health Organization. The evaluation and testing of drugs for mutagenicity- principles and problems. Geneva: WHO Tech Rep Ser No 482; 1971.
  14. Ames BN, Durston WE, Yamasaki E, Lee FD. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A 1973;70:2281-5. https://doi.org/10.1073/pnas.70.8.2281
  15. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983;113:173-215. https://doi.org/10.1016/0165-1161(83)90010-9
  16. Ishidate M Jr, Odashima S. Chromosome tests with 134 compounds on Chinese hamster cells in vitro--a screening for chemical carcinogens. Mutat Res 1977;48:337-53. https://doi.org/10.1016/0027-5107(77)90177-4
  17. Hayashi M, Kodama Y, Awogi T, Suzuki T, Asita AO, Sofuni T. The micronucleus assay using peripheral blood reticulocytes from mitomycin C- and cyclophosphamide-treated rats. Mutat Res 1992;278:209-13. https://doi.org/10.1016/0165-1218(92)90236-S
  18. Sawyer J, Moore MM, Clive D, Hozier J. Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line. Mutat Res 1985;147:243-53. https://doi.org/10.1016/0165-1161(85)90065-2
  19. McCann J, Choi E, Yamasaki E, Ames BN. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A 1975;72:5135-9. https://doi.org/10.1073/pnas.72.12.5135
  20. Meselson M, Russell K. Comparison of carcinogenic and mutagenic potency. In: Hiatt HH, Watson JD, Winstend JA, editors. Origin of human cancer. New York: Cold Spring Harbor Laboratory; 1977. p. 1473-81.
  21. Zimmermann FK. Induction of mitotic gene conversion by mutagens. Mutat Res 1971;11:327-37.
  22. Radman M, Jeggo P, Wagner R. Chromosomal rearrangement and carcinogenesis. Mutat Res 1982;98:249-64. https://doi.org/10.1016/0165-1110(82)90035-5
  23. Hayashi M, Sofuni T, Ishidate M Jr. High-sensitivity in micronucleus induction of a mouse strain (MS). Mutat Res 1982;105:253-6. https://doi.org/10.1016/0165-7992(82)90038-0
  24. Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate M Jr. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat Res 1990;245:245-9. https://doi.org/10.1016/0165-7992(90)90153-B
  25. Ryu JC, Kim SH, Kim KR, Lee SY, Kim MS, Chung HK, Park JS. A study on the antimutagenic effect of cinnamic acid derivatives in E. ColiPQ37 (SOS Chromotest). Environmental Mutagens and Carcinogens 1993;13:8-17.
  26. Hayashi M, Mäki-Paakkanen J, Tanabe H, Honma M, Suzuki T, Matsuoka A, Mizusawa H, Sofuni T. Isolation of micronuclei from mouse blood and fluorescence in situ hybridization with a mouse centromeric DNA probe. Mutat Res 1994;307:245-51. https://doi.org/10.1016/0027-5107(94)90298-4
  27. Heo MY, Kim JH, Ryu JC. Anticlastogenicity of carotene and galangin using in vivo supravital staining micronucleus test. Environmental Mutagens and Carcinogens 1997;17:92-6.
  28. Organization for Economic Co-operation and Development. Test No. 473: In vitro mammalian chromosome aberration test. OECD Guidelines for the Testing of Chemicals 1997;1:1-10.
  29. Galloway SM, Sofuni T, Shelby MD, Thilagar A, Kumaroo V, Kaur P, Gulati D, Putman DL, Murli H, Marshall R, Tanaka N, Anderson B, Zeiger E, Ishidate M Jr. Multilaboratory comparison of in vitro tests for chromosome aberrations in CHO and CHL cells tested under the same protocols. Environ Mol Mutagen 1997;29:189-207. https://doi.org/10.1002/(SICI)1098-2280(1997)29:2<189::AID-EM10>3.0.CO;2-A
  30. Ishidate M Jr, Sofuni T. The in vitro chromosomal aberration test using Chinese Hamster Lung (CHL) fibroblast cells in culture. In: Ashby J, editor. Progress in mutation research. Vol 5. New York: Elsevier Science Publishers; 1985. p. 427-32.
  31. National Institute of Environmental Research. GLP Notice No. 2008-44 for hazard assessment with chemicals in environment. Gwacheon (Korea): Ministry of Environment. 2008.
  32. Wang Z. DNA damage and mutagenesis. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. Hoboken, New Jersey: John Wiley & Sons, Inc; 2008. p. 471-3.
  33. Evans HJ. Cytological methods for detecting chemical mutagens. In: Hollaender A, editor. Chemical mutagens. Principles and methods for their detection. Vol 4. New York and London: Plenum Press; 1976. p. 1-29.
  34. Scott D, Galloway SM, Marshall RR, Ishidate M Jr, Ashby DBJ, Myhr BC. Genotoxicity under extreme culture conditions. A report from ICPEMC task group 9. Mutation Res 1991;257:147-204. https://doi.org/10.1016/0165-1110(91)90024-P
  35. Morita T, Nagaki T, Fukuda I, Okumura K. Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 1992;268:297-305. https://doi.org/10.1016/0027-5107(92)90235-T
  36. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R, Waters MD, Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 2000;463:111-72. https://doi.org/10.1016/S1383-5742(00)00049-1
  37. Bonassi S, Znaor A, Norppa H, Hagmar L. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet Genome Res 2004;104:376-82. https://doi.org/10.1159/000077519
  38. Norppa H. Cytogenetic biomarkers. In: Buffler P, Rice J, Baan R, Bird M, Boffetta P, editors. Mechanisms of carcinogenesis: contributions of molecular epidemiology. Lyon: IARC Sci. Publishers; 2004. p. 179-205.
  39. Bonassi S, Ugolini D, Kirsch-Volders M, Strömberg U, Vermeulen R, Tucker JD. Human population studies with cytogenetic biomarkers: review of the literature and future prospects. Environ Mol Mutagen 2005;45:258-70. https://doi.org/10.1002/em.20115
  40. A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage. Mutat Res 1990;241:325-37. https://doi.org/10.1016/0165-1218(90)90031-V
  41. Reuterwall C. A Nordic prospective study on the relationship between peripheral lymphocyte chromosome damage and cancer morbidity in occupational groups. Nordic Study Group on the Health Risk of Chromosome Damage. Prog Clin Biol Res 1990;340C:357-66.
  42. Brogger A, Hagmar L, Hansteen IL, Heim S, Högstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwalla C, Salomaaa S, Skerfvinga S, Sorsaa M. An inter-Nordicprospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Genet Cytogenet 1990;45:85-92. https://doi.org/10.1016/0165-4608(90)90071-H
  43. Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000;60:1619-25.
  44. Hagmar L, Brøgger A, Hansteen IL, Heim S, Högstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 1994;54:2919-22.
  45. Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H, Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998;58:4117-21.
  46. Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Högstedt B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat Res 1998;405:171-8. https://doi.org/10.1016/S0027-5107(98)00134-1
  47. Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Högstedt B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs. Recent Results Cancer Res 1998;154:177-84.
  48. Beetstra S, Thomas P, Salisbury C, Turner J, Fenech M. Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei. Mutat Res 2005;578:317-26. https://doi.org/10.1016/j.mrfmmm.2005.05.012